AUGMENTIN - Food and Drug Administration The duration of therapy should be determined by the response of the patient. osteomyelitis) require longer periods of treatment. Treatment should not be extended beyond 14 days without review (see section 4.4 regarding prolonged therapy). NDA 050564/S-020/S-025 Page 3 AUGMENTIN® amoxicillin/clavulanate potassium Tablets To reduce the development of drug-resistant bacteria and maintain
Votre compagnon shopping ciao.fr Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents (see sections 4.3 and 4.8). Fr
Augmentin - FDA prescribing The use of alternative presentations of Augmentin (e.g. Augmentin official prescribing information for healthcare professionals. Includes indications, dosage, adverse reactions, pharmacology and more.
Amoxicillin to clavulanate ratio - nmwj. Those that provide hher doses of amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as necessary (see sections 4.4 and 5.1). Amoxicillin to clavulanate ratio Amoxicillin/clavulanic acid, also known as co-amoxiclav. Medscape - Indication-specific dosing for Augmentin.